AGEN
Agenus Inc
$3.08
0.09 (2.86%) Today
0.02 (0.65%) After-hours
— up— down
Market Cap
$127M-33.0%
Revenue (TTM)
$134.72M+24.5%
Net Income (TTM)
$69.46M
$69.46MEPS (TTM)
1.67
1.67Shares Out
41.64M
41.64MP/E Ratio
2.03
2.03Forward P/E
5.09
5.09Open
$3.18
$3.18Previous Close
$3.15
$3.15Day Range
$3.02 – $3.20
$3.02 – $3.2052-Week Range
$2.71 – $7.34
$2.71 – $7.34Beta
1.57
1.57Volume
615.02K
615.02KAvg Volume
784.20K
784.20KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout AGEN
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.